Logo image
First-generation adenovirus vectors shorten survival time in a murine model of sepsis
Journal article   Peer reviewed

First-generation adenovirus vectors shorten survival time in a murine model of sepsis

Kevin Doerschug, Salih Sanlioglu, Dawn M Flaherty, Rebecca L Wilson, Timur Yarovinsky, Martha M Monick, John F Engelhardt and Gary W Hunninghake
The Journal of immunology (1950), Vol.169(11), pp.6539-6545
12/01/2002
DOI: 10.4049/jimmunol.169.11.6539
PMID: 12444165

View Online

Abstract

Adverse immunological reactions to adenoviral vectors have significantly impacted the utility of this virus for treating genetic and environmentally induced diseases. In this study, we evaluate the effect of adenoviral vectors on an animal model of sepsis. Systemic delivery of first-generation adenoviral vectors to septic mice (cecal ligation and puncture) resulted in a shortened survival time. This effect was not observed with second-generation or inactivated first-generation vectors. The accelerated death was accompanied by a number of important changes in the disease. These changes included increased liver cell apoptosis (including Kupffer cells) and a marked increase in liver bacterial load. In the lung, the combination induced an increase in bacterial load, as well as greater lung injury. In the serum, the combination was associated with decreased TNF-alpha levels and an increase in bacterial load. Finally, a profound degree of lymphocyte apoptosis was observed in these animals. These observations suggest that prior exposure to first-generation adenovirus gene therapy vectors may worsen the outcome of some forms of sepsis.
Tumor Necrosis Factor-alpha - metabolism Kupffer Cells - pathology Lung - microbiology Liver - pathology Lung - pathology Sepsis - immunology Mice, Inbred C57BL Liver - microbiology Colony Count, Microbial Lymphocytes - pathology Animals Sepsis - pathology Sepsis - therapy Thymus Gland - pathology Adenoviridae - genetics Female Mice Safety Genetic Vectors Spleen - pathology Genetic Therapy - adverse effects Genetic Therapy - methods

Details

Metrics

Logo image